MAP/ICP/CPP (mmHg) | T0 pre-injury | T1 | T2 | T3 | T4 |
---|---|---|---|---|---|
SV02 (%)/CCO (L/min) | MAP | ||||
Subject 1 | 97 | 114/43/71 | 76/23/53 | 74/24/50 | 79/29/50 |
72/3.1 | 75/3.0 | 74/2.6 | 77/3.6 | 84/4.7 | |
Subject 2 | 98 | 74/23/51 | 91/30/61 | 79/29/50 | 92/42/50 |
NA/2.5 | NA/2.4 | NA/2.5 | NA/2.5 | NA/3.0 | |
Subject 3 | 110 | 100/NA/NA | 90/NA/NA | 130/NA/NA | 125/NA/NA |
75/3.4 | 79/3.4 | 66/2.9 | 69/3.1 | 77/4.1 | |
Subject 4 | 117 | 106/23/83 | 137/23/114 | 130/23/107 | 135/25/110 |
70/4.6 | 70/4.7 | 71/3.8 | 72/3.9 | 74/5.7 | |
Subject 5 | 114 | 97/23/74 | 72/21/51 | 79/25/54 | 94/27/67 |
85/4.0 | 79/3.6 | 78/3.7 | 80/3.7 | 86/5.9 | |
Subject 6 | 90 | 99/12/87 | 100/13/87 | 92/13/79 | 81/10/71 |
77/3.2 | 73/3.2 | 66/2.3 | 61/2.3 | 86/5.7 | |
Subject 7 | 90 | 70/22/48a | 70/35/35a | 80/46/34a | 90/67/23a |
92/4.6 | 98/4.1 | 98/4.7 | 97/3.3 | 98/3.9 | |
Subject 8 | 110 | 80/7/73 | 79/6/73 | 90/4/86 | 95/4/91 |
83/4.8 | 87/4.3 | 87/5.1 | 86/4.5 | 87/6.2 | |
Subject 9 | 90 | 90/8/82 | 94/6/88 | 95/5/90 | 103/4/99 |
54/2.9 | 51/3.1 | 53/3.2 | 66/3.7 | 69/5.5 | |
Subject 10 | 72 | 94/6/88 | 97/5/92 | 77/4/73 | 109/4/105 |
NA/2.7 | NA/3.0 | NA/3.0 | NA/4.1 | NA/5.6 | |
Subject 11 | 130 | 133/2/131 | 124/5/119 | 108/3/105 | 128/3/125 |
74/3.3 | 76/3.6 | 70/3.0 | 78/4.3 | 80/5.4 | |
Subject 12 | 107 | 125/26/99 | 118/21/97 | 90/19/71 | 114/13/101 |
71/3.4 | 71/3.2 | 72/3.1 | 71/3.2 | 72/4.0 |